Session Details
[1T06]Biology of Diseases 01
Wed. Nov 6, 2024 11:05 AM - 12:35 PM JST
Wed. Nov 6, 2024 2:05 AM - 3:35 AM UTC
Wed. Nov 6, 2024 2:05 AM - 3:35 AM UTC
Room6(G302)
Organizers: Maki Tsujita(Nagoya City University Graduate School of Medical Sciences), Ken Saito(Dep. Clin. Eng. Med. Tech. Niigata Univ. Health and Welfare)
[1T06-01]Fatty Acid Desaturase 2 (FADS2) promotes tumorigenesis in cholangiocarcinoma
○Haruna Fujimori1, Hasegawa Kohsei1, Kohta Nakatani2, Masatomo Takahashi2, Yoshihiro Izumi2, Takeshi Bamba2, Rie Shibuya-Takahashi1, Mai Mochizuki1, Kazunori Yamaguchi3, Jun Yasuda3, Naoki Asano1, Keiichi Tamai1 (1.Div. Cancer Stem Cell, Miyagi Cancer Ctr. Res. Inst., 2.Med. Inst. Bioreg., Kyushu Univ., 3.Div. Mol. & Cell. Oncol., Miyagi Cancer Ctr. Res. Inst.)
キーテクノロジー:リピドミクス、PDX
[1T06-02]Phospholipase, PNPLA6 relates to the regulation of cell membrane lipid in malignant transformation
○Rina Takamiya1,2, Yuki Nagasaki2, Hiromu Suzuki3, Makoto Murakami2,4 (1.Dept. of Biochem., Sch.of Med., Hyogo Med. Univ., 2.CDBIM, Grad. Sch. of Med., The Univ. of Tokyo, 3.Dept. of Mol. Biol., Sch. of Med., Sapporo Med. Univ., 4.AMED-CREST)
キーテクノロジー:リピドミクス解析
[1T06-03]Concurrent inhibition of GSK3 and MEK as a novel strategy to treat pancreatic cancer
○Masahiro Sonoshita (Institute for Genetic Medicine, Hokkaido University)
キーテクノロジー:Whole-body phenotypic screen
[1T06-04]Exploring of diagnostic markers for urothelial carcinoma
○Tsutomu Fujimura, Sachiko Komatsu (Tohoku Medical and Pharmaceutical University)
キーテクノロジー:診断マーカー
[1T06-05]Detection of Cancer-specific exosomes using the exosome-counting system ExoCounter
○Yasuaki Kabe (Department of Biochemistry, Kochi Medical Schoool, Kochi University)
キーテクノロジー:エクソソーム絶対計測システム
[1T06-06]E3 ubiquitin ligase MIB1 regulates PLK1, induces chromosomal instability and is involved in malignant transformation in glioma
○Keiji Koshiba1, Jingyu Lu2, Yuki Ohta2, Takamasa Mizoguchi2, Motoyuki Itoh2 (1.Faculty of Pharmaceutical Science, Chiba University, 2.Graduate School of Pharmaceutical Sciences, Chiba University)
キーテクノロジー:ゼノグラフト
[1T06-07]Establishment of a glioblastoma cell line accumulating the rare phospholipid PI(5)P
○Miko Oikawa1, Kaoru Tamura2, Haruka Abeki1, Shin Morioka1, Toshiyoshi Yamamoto1, Jyunko Sasaki1, Takehiko Sasaki1 (1.Department of Biochemical Pathophysiology, Medical Research Institute, Tokyo Medical and Dental University, 2.Department of Functional Neurosurgery, Tokyo Medical and Dental University)
キーテクノロジー:LC-MS/MS
[1T06-08]Elucidation of the mechanism by which the ubiquitin ligase MKRN1 suppresses ferroptosis
○Yutaro Yamada, Yusuke Hirata, Takuya Noguchi, Atsushi Matsuzawa (Lab. of Health Chem., Grad. Sch. of Pharmaceut. Sci., Tohoku Univ.)
キーテクノロジー:次世代シーケンス
[1T06-09]Anti-cancer effect of the novel geldanamycin derivatives targeting NRF2-activated esophageal squamous cell carcinoma
○Hiroyuki Oshikiri, Keiko Taguchi, Liam Baird, Masayuki Yamamoto (Department of Biochemistry and Molecular Biology, Tohoku Medical Megabank Organization, Tohoku University)
キーテクノロジー:キノン代謝による薬剤の活性化
[1T06-10]Activation of the WDR1 gene by deregulated E2F1 forms positive feedback loop in tumor suppressive E2F1 activity
○Mashiro Shirasawa, Kiyoshi Ohtani (Dept. of Biomed. Chem. Grad. Sch. of Sci. and Tech. Kwansei Gakuin Univ.)
キーテクノロジー:遺伝子発現制御